Somogyi A, Bochner F, Chen Z R
Department of Clinical Pharmacology, Royal Adelaide Hospital, Australia.
Eur J Clin Pharmacol. 1991;41(4):379-82. doi: 10.1007/BF00314972.
Plasma and urine concentrations of codeine and its measurable metabolites were determined by HPLC in six healthy subjects after a single 30 mg oral dose of codeine either alone or after 7 doses of 1 g paracetamol 8 hourly. After codeine alone, the t1/2 (h), AUC (mumol.l-1.h) and CLR (ml.min-1) for codeine were 2.2, 0.81, and 252 respectively. These were not significantly altered by paracetamol: 2.2, 0.84, and 291 respectively. For codeine-6-glucuronide the values were 2.4, 22.0, and 29.7 respectively. These were not significantly different from those after codeine plus paracetamol: 2.4, 21.9, and 39.6. There were no significant differences between the two treatments in the apparent partial clearances (ml.min-1) of codeine to morphine (88 codeine alone, 70 codeine plus paracetamol), to norcodeine (71 codeine alone, 88 codeine plus paracetamol), and to codeine-6-glucuronide (820 codeine alone, 1022 codeine plus paracetamol). The urinary excretion of codeine-6-glucuronide, morphine, norcodeine, and codeine were not significantly different between the two treatments.
在六名健康受试者中,单次口服30毫克可待因(单独服用或在每8小时服用7剂1克对乙酰氨基酚后服用)后,通过高效液相色谱法测定了血浆和尿液中可待因及其可测量代谢物的浓度。单独服用可待因后,可待因的t1/2(小时)、AUC(微摩尔·升-1·小时)和CLR(毫升·分钟-1)分别为2.2、0.81和252。这些值未因对乙酰氨基酚而发生显著改变:分别为2.2、0.84和291。对于可待因-6-葡萄糖醛酸,其值分别为2.4、22.0和29.7。这些值与可待因加对乙酰氨基酚后的数值无显著差异:分别为2.4、21.9和39.6。两种治疗方法在可待因向吗啡(单独服用可待因时为88,可待因加对乙酰氨基酚时为70)、向去甲可待因(单独服用可待因时为71,可待因加对乙酰氨基酚时为88)以及向可待因-6-葡萄糖醛酸(单独服用可待因时为820,可待因加对乙酰氨基酚时为1022)的表观部分清除率(毫升·分钟-1)方面无显著差异。两种治疗方法在可待因-6-葡萄糖醛酸、吗啡、去甲可待因和可待因的尿排泄方面无显著差异。